Hyundai ADM Bio Inc. (KOSDAQ:187660)
 2,930.00
 -170.00 (-5.48%)
  At close: Oct 28, 2025
Hyundai ADM Bio Revenue
In the year 2024, Hyundai ADM Bio had annual revenue of 9.74B KRW, down -29.33%.
Revenue 
 9.74B
Revenue Growth 
 -29.33%
P/S Ratio 
 14.64
Revenue / Employee 
 60.91M
Employees 
 160
Market Cap 
142.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 9.74B | -4.05B | -29.33% | 
| Dec 31, 2023 | 13.79B | -1.09B | -7.34% | 
| Dec 31, 2022 | 14.88B | 904.78M | 6.47% | 
| Dec 31, 2021 | 13.98B | 857.61M | 6.54% | 
| Dec 31, 2020 | 13.12B | 2.91B | 28.55% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Electronics | 308.59T | 
| Hyundai Motor Company | 182.25T | 
| Kia Corporation | 111.04T | 
| SK hynix | 77.21T | 
| LG Energy Solution | 25.16T | 
| Hanwha Aerospace | 19.25T | 
| Doosan Enerbility | 16.30T | 
| HD Hyundai Heavy Industries | 15.58T |